CRISPR Therapeutics AG (NASDAQ:CRSP) Sees Large Decrease in Short Interest

CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) was the recipient of a large decrease in short interest during the month of January. As of January 31st, there was short interest totalling 15,740,000 shares, a decrease of 7.6% from the January 15th total of 17,040,000 shares. Based on an average daily volume of 2,800,000 shares, […]

Related Keywords

Canada ,Samarth Kulkarni ,Royal Bank ,Headlands Technologies ,Wolfe Research ,Securities Exchange Commission ,Therapeutics Company Profile ,Tradewinds Capital Management ,Barclays ,Morgan Stanley ,Blue Trust Inc ,Geneos Wealth Management Inc ,Get Free Report ,Exchange Commission ,Wealth Management ,Capital Management ,Trading Down ,Crispr Therapeutics ,Nasdaq Crsp ,Crsp ,Medical ,Stocks ,Options ,Put ,Call ,